Intranasal esketamine: real-world clinical practice in treatment-resistant depression and factors associated with treatment response.
Bernhard T Baune, Kevin Rosemann, Dimitri Hefter, Mustafa Tonkul, Erhan Kavakbasi
BMC Psychiatry March 17, 2026 DOI: 10.1186/s12888-026-07980-8 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Population | Patients with treatment-resistant depression receiving intranasal esketamine in real-world clinical practice |
| Intervention | Intranasal esketamine |
| Topics | Depression Esketamine |
| Citations | 2 |
| Key findings | Intranasal esketamine is effective in real-world treatment of treatment-resistant depression, with response influenced by patient-specific factors. |
Abstract
Intranasal esketamine: real-world clinical practice in treatment-resistant depression and factors associated with treatment response.